New diabetes clinical trial: Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)

Published on: June 28, 2023 at 11:00AM
Conditions:   Gestational Diabetes Mellitus;   Pregnancy in Diabetic;   Pregnancy, High Risk
Interventions:   Drug: Patient-led Insulin (intervention group);   Drug: Provider-led Insulin (standard care)
Sponsor:   Ohio State University
Not yet recruiting
https://ift.tt/9tVHwL8

Comments